Proteins Marking the Sequence of Genotoxic Signaling from Irradiated Mesenchymal Stromal Cells to CD34+ Cells.
Aged
Antigens, CD34
/ metabolism
Biomarkers
Bone Marrow Cells
/ cytology
Cell Differentiation
/ genetics
Cell Survival
/ genetics
Chromosomal Instability
Culture Media, Conditioned
/ metabolism
DNA Damage
Endoplasmic Reticulum Chaperone BiP
Female
Histones
/ metabolism
Humans
Male
Mesenchymal Stem Cells
/ cytology
Models, Biological
Proteome
Proteomics
/ methods
Radiation, Ionizing
Reactive Oxygen Species
/ metabolism
Signal Transduction
/ radiation effects
CD34+ cells
genotoxic signals
irradiation
mesenchymal stromal cells
myeloid neoplasms
non-targeted effects
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
29 May 2021
29 May 2021
Historique:
received:
14
03
2021
revised:
19
05
2021
accepted:
26
05
2021
entrez:
2
6
2021
pubmed:
3
6
2021
medline:
22
6
2021
Statut:
epublish
Résumé
Non-targeted effects (NTE) of ionizing radiation may initiate myeloid neoplasms (MN). Here, protein mediators (I) in irradiated human mesenchymal stromal cells (MSC) as the NTE source, (II) in MSC conditioned supernatant and (III) in human bone marrow CD34+ cells undergoing genotoxic NTE were investigated. Healthy sublethal irradiated MSC showed significantly increased levels of reactive oxygen species. These cells responded by increasing intracellular abundance of proteins involved in proteasomal degradation, protein translation, cytoskeleton dynamics, nucleocytoplasmic shuttling, and those with antioxidant activity. Among the increased proteins were THY1 and GNA11/14, which are signaling proteins with hitherto unknown functions in the radiation response and NTE. In the corresponding MSC conditioned medium, the three chaperones GRP78, CALR, and PDIA3 were increased. Together with GPI, these were the only four altered proteins, which were associated with the observed genotoxic NTE. Healthy CD34+ cells cultured in MSC conditioned medium suffered from more than a six-fold increase in γH2AX focal staining, indicative for DNA double-strand breaks, as well as numerical and structural chromosomal aberrations within three days. At this stage, five proteins were altered, among them IQGAP1, HMGB1, and PA2G4, which are involved in malign development. In summary, our data provide novel insights into three sequential steps of genotoxic signaling from irradiated MSC to CD34+ cells, implicating that induced NTE might initiate the development of MN.
Identifiants
pubmed: 34072546
pii: ijms22115844
doi: 10.3390/ijms22115844
pmc: PMC8197937
pii:
doi:
Substances chimiques
Antigens, CD34
0
Biomarkers
0
Culture Media, Conditioned
0
Endoplasmic Reticulum Chaperone BiP
0
HSPA5 protein, human
0
Histones
0
Proteome
0
Reactive Oxygen Species
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Stefan Jentsch Fellowship, Deutsche Gesellschaft für DNA-Reparaturforschung (DGDR)
ID : Stefan Jentsch Fellowship 2020
Organisme : José Carreras Leukämie-Stiftung
ID : DJCLS 14R/2017, DJCLS H 03/01
Références
Lancet Oncol. 2009 Jul;10(7):718-26
pubmed: 19573801
Nat Rev Cancer. 2007 Sep;7(9):673-83
pubmed: 17721432
J Biol Chem. 2010 Feb 26;285(9):6725-38
pubmed: 20022947
Radiat Res. 1996 Oct;146(4):369-73
pubmed: 8927708
Clin Cancer Res. 2013 Dec 15;19(24):6802-11
pubmed: 24048331
Cancer Res. 2003 Dec 1;63(23):8437-42
pubmed: 14679007
Br J Cancer. 2008 Jun 3;98(11):1839-44
pubmed: 18475304
Semin Cancer Biol. 2016 Jun;37-38:65-76
pubmed: 26721424
Arch Biochem Biophys. 1995 Nov 10;323(2):397-403
pubmed: 7487104
BMB Rep. 2017 Aug;50(8):401-410
pubmed: 28648146
Nat Cell Biol. 2005 Aug;7(8):766-72
pubmed: 16056268
Semin Cancer Biol. 2016 Jun;37-38:77-95
pubmed: 26873647
Oncogene. 2008 Jan 17;27(4):434-40
pubmed: 17621264
Cell Death Dis. 2018 Nov 15;9(12):1142
pubmed: 30442925
Nat Rev Cancer. 2009 May;9(5):351-60
pubmed: 19377507
J Biol Chem. 2009 Nov 20;284(47):32305-11
pubmed: 19801670
Proc Natl Acad Sci U S A. 2008 Jul 29;105(30):10320-5
pubmed: 18650382
Clin Cancer Res. 2016 Jul 1;22(13):3320-7
pubmed: 26813358
PLoS One. 2010 Dec 02;5(12):e14195
pubmed: 21152027
Proc Natl Acad Sci U S A. 2000 Feb 29;97(5):2099-104
pubmed: 10681418
RNA Biol. 2015;12(12):1355-63
pubmed: 26488306
Cancers (Basel). 2019 Nov 13;11(11):
pubmed: 31766302
Radiat Res. 2006 Apr;165(4):400-9
pubmed: 16579652
Int J Radiat Biol. 2011 Jul;87(7):683-95
pubmed: 21294691
Proc Natl Acad Sci U S A. 2001 Jan 16;98(2):473-8
pubmed: 11149936
Radiat Res. 2003 Sep;160(3):318-23
pubmed: 12926990
Int J Radiat Biol. 2013 Dec;89(12):1028-34
pubmed: 23786650
Cancer Res. 2005 Jul 1;65(13):5668-73
pubmed: 15994940
Cancer Res. 2000 Oct 15;60(20):5608-11
pubmed: 11059747
J Cell Mol Med. 2012 Apr;16(4):877-87
pubmed: 21762375
J Biol Chem. 2012 Feb 10;287(7):4434-40
pubmed: 21832045
Blood. 2012 Jan 19;119(3):817-25
pubmed: 21937694
Biochem J. 2011 Mar 1;434(2):181-8
pubmed: 21309747
Nat Rev Cancer. 2017 Aug 24;17(9):513-527
pubmed: 28835720
Cytotherapy. 2006;8(4):315-7
pubmed: 16923606
Mol Carcinog. 2008 Oct;47(10):806-13
pubmed: 18381585
Cell Death Dis. 2019 Apr 5;10(4):309
pubmed: 30952835
Radiat Res. 2010 Jun;173(6):769-78
pubmed: 20518656
Cancers (Basel). 2019 Aug 23;11(9):
pubmed: 31450803
Free Radic Res. 2012 Apr;46(4):382-419
pubmed: 22276778
Cancer Sci. 2018 Sep;109(9):2632-2640
pubmed: 29949679
Blood. 2012 Apr 5;119(14):3321-9
pubmed: 22323447
Blood. 2009 Oct 29;114(18):3960-7
pubmed: 19713465
Cancer Res. 1992 Nov 15;52(22):6394-6
pubmed: 1423287
PLoS One. 2018 Apr 5;13(4):e0195371
pubmed: 29621312
Cancer Res. 2002 Aug 1;62(15):4484-90
pubmed: 12154059
J Hum Genet. 2010 Feb;55(2):118-20
pubmed: 19927161
Cell Stem Cell. 2011 Oct 4;9(4):330-44
pubmed: 21982233
Cell Res. 2021 Jan;31(1):5-16
pubmed: 32733014
Cell Signal. 2009 Oct;21(10):1471-8
pubmed: 19269319
Stem Cells. 1995 Sep;13(5):524-32
pubmed: 8528102
Cells. 2020 Jul 10;9(7):
pubmed: 32664328
Nature. 2017 Jul 27;547(7664):458-462
pubmed: 28723894
J Vis Exp. 2017 Nov 3;(129):
pubmed: 29155797
Cancer Res. 2003 Jan 1;63(1):242-9
pubmed: 12517804
Leukemia. 2010 Apr;24(4):679-86
pubmed: 20130602
Sci Rep. 2019 Jun 24;9(1):9103
pubmed: 31235776
Clin Cancer Res. 2014 Mar 15;20(6):1410-6
pubmed: 24520092
Curr Opin Cell Biol. 2015 Apr;33:8-13
pubmed: 25305438
Cytokine. 2013 Jan;61(1):54-62
pubmed: 23022376
Nat Rev Mol Cell Biol. 2020 Aug;21(8):421-438
pubmed: 32457508
Cancer Res. 2008 Apr 1;68(7):2233-40
pubmed: 18381429
EBioMedicine. 2018 Jul;33:22-32
pubmed: 29907328
Leuk Res. 2017 Feb;53:20-27
pubmed: 27951415
Cancer Res. 2008 Oct 1;68(19):8122-6
pubmed: 18829571
Science. 1997 Jan 3;275(5296):86-8
pubmed: 8974399
Leuk Res. 2017 Jun;57:112-118
pubmed: 28359030
Oncogene. 2005 Feb 10;24(7):1212-9
pubmed: 15592519
Front Oncol. 2018 Jul 09;8:254
pubmed: 30038898
Cancer Res. 2007 Jun 15;67(12):5872-9
pubmed: 17575156
Mol Carcinog. 2008 Mar;47(3):235-44
pubmed: 17918192
Nat Rev Cancer. 2004 Feb;4(2):158-64
pubmed: 14964312